Background/Aims Glypican-3 (GPC3) protein is highly expressed in hepatocellular carcinoma (HCC) tissue. It has been suggested as a diagnostic biomarker, but its inconsistent performance means that it requires further assessment. We therefore investigated the diagnostic value of the plasma GPC3 level compared to the alpha-fetoprotein (AFP) level as a diagnostic biomarker of HCC.
Methods We enrolled 157 consecutive patients with newly diagnosed HCC and 156 patients with liver cirrhosis (LC) as the control group. GPC3 plasma levels were measured using two commercially available enzyme-linked immunosorbent assays (ELISAs, named as Assay 1 and 2), and AFP levels were measured using an enzyme-linked chemiluminescent immunoassay. The diagnostic accuracy was analyzed using the receiver operating characteristics (ROC) curve.
Results Plasma GPC3 levels in HCC patients were very low (0–3.09 ng/mL) in Assay 1, while only 3 of the 157 patients (1.9%) showed detectable GPC3 levels in Assay 2. The median GPC3 level was not significantly elevated in the HCC group (0.80 ng/mL) compared with the LC group (0.60 ng/mL). The area under the ROC curve (AUC) for GPC3 was 0.559 in Assay 1. In contrast, the median AFP level was significantly higher in HCC (27.72 ng/mL) than in LC (4.74 ng/mL), with an AUC of 0.729.
Conclusions The plasma level of GPC3 is a poor diagnostic marker for HCC, being far inferior to AFP. The development of a consistent detection system for the blood level of GPC3 is warranted.
Citations
Citations to this article as recorded by
An ingenious electrochemical system based on naphthalenediimide derivatives for ultrasensitive immunosensing of alpha-fetoprotein Ling-Yu Zhao, Guo-Dong Shen, De-He Wang, Wei Zhang, Huai-Qing Zhao, Rong-Na Ma, Huai-Sheng Wang Talanta.2025; 283: 127135. CrossRef
A dual-signal output electrochemical aptasensor for glypican-3 ultrasensitive detection based on reduced graphene oxide-cuprous oxide nanozyme catalytic amplification strategy Guiyin Li, Huafu Feng, Xinhao Li, Shengnan Li, Jintao Liang, Zhide Zhou Bioelectrochemistry.2024; 158: 108709. CrossRef
Normal Glypican-3 Serum Levels Do Not Eliminate the Risk of Hepatocellular Carcinoma Agnieszka Lembas, Tomasz Mikuła, Magdalena Suchacz, Joanna Kozłowska, Szymon Barczak, Barbara Badura, Alicja Wiercińska-Drapało Galician Medical Journal.2024;[Epub] CrossRef
A chemiluminescence immunosensor for biomarker detection based on boronic acid-modified magnetic composite microspheres Xiuli Wang, Leyi He, Yaoxia Li, Jia Guo, Changchun Wang Journal of Materials Chemistry B.2024; 12(40): 10285. CrossRef
A fluorescence aptasensor based on GSH@GQDs and RGO for the detection of Glypican-3 Huixue Wang, Jinya Liu, Wei Chen, Jintong Na, Yong Huang, Guiyin Li Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2022; 270: 120798. CrossRef
Clinical implications of exosome-derived noncoding RNAs in liver Zhe Wen Zhou, Wei Zheng, Zheng Xiang, Cun Si Ye, Qiao Qiao Yin, Shou Hao Wang, Cheng An Xu, Wen Hao Wu, Tian Chen Hui, Qing Qing Wu, Ling Yun Zhao, Hong Ying Pan, Ke Yang Xu Laboratory Investigation.2022; 102(5): 464. CrossRef
Label-free detection of glypican-3 using reduced graphene oxide /polyetherimide/gold nanoparticles enhanced aptamer specific sensing interface on light-addressable potentiometric sensor Guiyin Li, Bo Wang, Le Zhao, Xiaohang Shi, Guanxiong Wu, Wei Chen, Lixian Sun, Jintao Liang, Zhide Zhou Electrochimica Acta.2022; 426: 140808. CrossRef
Preparation of an electrochemical immunosensor based on a Cu/Cu2O-rGO@Au signal synergistic amplification strategy and efficient and sensitive detection of alpha-fetoprotein Min Wang, Mingzhe Jiang, Xiaochen Liao, Xiao Wang, Wenjing Lai, Pengli Li, Jiajia Li, Chenglin Hong, Yu Qi Analytical Methods.2022; 14(27): 2703. CrossRef
Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition Sangmi Jang, Gwang Hyeon Choi, Won Chang, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong, Nobuyuki Takahashi PLOS ONE.2022; 17(7): e0271407. CrossRef
Highly sensitive electrochemical aptasensor for Glypican-3 based on reduced graphene oxide-hemin nanocomposites modified on screen-printed electrode surface Guiyin Li, Huafu Feng, Xiaohang Shi, Min Chen, Jintao Liang, Zhide Zhou Bioelectrochemistry.2021; 138: 107696. CrossRef
Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine Nurbubu Moldogazieva, Innokenty Mokhosoev, Sergey Zavadskiy, Alexander Terentiev Biomedicines.2021; 9(2): 159. CrossRef
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza Cochrane Database of Systematic Reviews.2021;[Epub] CrossRef
Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis Yucel Aydin, Ali Riza Koksal, Paul Thevenot, Srinivas Chava, Zahra Heidari, Dong Lin, Tyler Sandow, Krzysztof Moroz, Mansour A Parsi, John Scott, Ari Cohen, Srikanta Dash Journal of Hepatocellular Carcinoma.2021; Volume 8: 1579. CrossRef
Label-free electrochemical aptasensor based on reduced graphene oxide–hemin–chitosan nanocomposite for the determination of glypican-3 Min Chen, Haimei Li, Xueming Su, Runqiang Wu, Huafu Feng, Xiaohang Shi, Jintao Liang, Jiejing Chen, Guiyin Li New Journal of Chemistry.2021; 45(19): 8608. CrossRef
Diagnostic value of serum glypican-3 alone and in combination with AFP as an aid in the diagnosis of liver cancer Shuxia Liu, Minjie Wang, Cuiling Zheng, Qiaofeng Zhong, Yuankai Shi, Xiaohong Han Clinical Biochemistry.2020; 79: 54. CrossRef
Soluble cluster of differentiation 26/soluble dipeptidyl peptidase-4 and glypican-3 are promising serum biomarkers for the early detection of Hepatitis C virus related hepatocellular carcinoma in Egyptians Salwa H. Gomaa, Mona M. Abaza, Hoda A. Elattar, Gamal A. Amin, Doaa M. Elshahawy Arab Journal of Gastroenterology.2020; 21(4): 224. CrossRef
Blood exosomal micro ribonucleic acid profiling reveals the complexity of hepatocellular carcinoma and identifies potential biomarkers for differential diagnosis Lang-Qing Sheng, Jia-Rong Li, Hao Qin, Ling Liu, Da-Dong Zhang, Qi Zhang, Meng-Li Huang, Xiao-Li Li, Xiao-Ya Xu, Yang-Nian Wei, Zi-Shuo Chen, Hui Luo, Ji-Yang Zhang, Cheng-Hui Zhou, Hao Chen, Ze-Guo Chen, Fu-Gen Li, Nian-Feng Li World Journal of Gastrointestinal Oncology.2020; 12(10): 1195. CrossRef
Improving the Detection of Hepatocellular Carcinoma using serum AFP expression in combination with GPC3 and micro-RNA miR-122 expression Jian Li, Sun Qiyu, Tiezheng Wang, Boxun Jin, Ning Li Open Life Sciences.2019; 14(1): 53. CrossRef
Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis Dahai Xu, Chang Su, Liang Sun, Yuanyuan Gao, Youjun Li Annals of Hepatology.2019; 18(1): 58. CrossRef
Influence of Glypican-3 as Anewly Diagnostic Biomarker in Earlydetection of Hepatocellular Carcinoma among Saudi Patients Randa Mohamed MA Farag, Dujana AlAyobi, Khalid A Alsaleh, Hye-Joo Kwon, Afaf EL-Ansary, Emad Anwar Dawoud Biomedical and Pharmacology Journal.2018; 11(4): 1789. CrossRef
Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review) Jing‑Hua Pan, Hong Zhou, Xiao‑Xu Zhao, Hui Ding, Wei Li, Li Qin, Yun‑Long Pan International Journal of Molecular Medicine.2018;[Epub] CrossRef
Dual signal amplification strategy of Au nanopaticles/ZnO nanorods hybridized reduced graphene nanosheet and multienzyme functionalized Au@ZnO composites for ultrasensitive electrochemical detection of tumor biomarker Xian Fang, Junfeng Liu, Jing Wang, Hong Zhao, Hongxuan Ren, Zengxi Li Biosensors and Bioelectronics.2017; 97: 218. CrossRef
First
Prev
